<DOC>
	<DOCNO>NCT02509338</DOCNO>
	<brief_summary>The main objective trial study technical feasibility implantation new electrode Monocontact deep brain stimulation electrode dystonia .</brief_summary>
	<brief_title>Validation Implantation New Electrode Treatment Dystonia</brief_title>
	<detailed_description>Deep brain stimulation ( DBS ) validate therapy treat dystonia movement disorder . The main therapeutical target use treat dystonic syndrome internal globus pallidum ( GPi ) . Given morphology topography nucleus , base experience efficient therapy use one two contact available four contact standard DBS lead , design two new electrode , one one contact-electrode one two contact-electrodes , aim limit side effect relate internal globus pallidum DBS provide homogeneous electric field around electrode within GPi maintain therapeutical outcome . The main objective trial study technical feasibility implantation new one contact-electrode ( Monopolar DBS Lead Model 09064-40cm ) treat isolated generalized/segmental dystonia tardive dystonia . The second main objective study assess safety implantation new device . The secondary objective explore therapeutical effect DBS use new monocontact electrode study electrical field generate around monocontact electrode within GPi . The study prospective patient recruit Tertiary Movement Disorders Clinic . Seven subject recruit study .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>Age superior 18 year inferior 65 year Generalized segmental isolate dystonia tardive dystonia Diagnosis base history , clinical examination , checkup without abnormality normal brain MRI allow exclusion secondary degenerative dystonias Unsufficient response pharmacological treatment ( improvement &lt; 30/ % clinical dystonia scale ) No comorbidity interfere general anesthesia , represent contraindication neurosurgical procedure followup trial Consent patient Insurance affiliation Followup possible 12 month Available insurance operate patient No possibility clinical followup Acquired dystonia except tardive dystonia MRI generalize anesthesia contraindicate Anticoagulant treatment antiaggregant treatment Pregnancy Ongoing participation another clinical trial Guardianship Trusteeship Person deprive liberty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>